BEXIMCO PHARMAGDR Financials

BEXIMCO PHARMAGDR Stock Summary

BEXIMCO PHARMAGDR competes with Merck KGaA, Haleon PLC, LIVZON PHARMAC, SIMCERE PHARMAC, and CanSino Biologics. Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulation products and active pharmaceutical ingredients. Beximco Pharmaceuticals Limited was founded in 1976 and is headquartered in Dhaka, Bangladesh. Beximco Pharmaceuticals operates under Drug Manufacturers - Major classification in Germany and traded on Frankfurt Stock Exchange.

BEXIMCO PHARMAGDR Key Financial Ratios

There are many critical financial ratios that BEXIMCO PHARMAGDR's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that BEXIMCO PHARMAGDR REGS reports annually and quarterly.

BEXIMCO Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining BEXIMCO PHARMAGDR's current stock value. Our valuation model uses many indicators to compare BEXIMCO PHARMAGDR value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BEXIMCO PHARMAGDR competition to find correlations between indicators driving BEXIMCO PHARMAGDR's intrinsic value. More Info.BEXIMCO PHARMAGDR REGS is rated below average in return on equity category among its peers. It is rated third in return on asset category among its peers reporting about  0.57  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for BEXIMCO PHARMAGDR REGS is roughly  1.76 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BEXIMCO PHARMAGDR's earnings, one of the primary drivers of an investment's value.

BEXIMCO PHARMAGDR REGS Systematic Risk

Along with financial statement analysis, the daily predictive indicators of BEXIMCO PHARMAGDR help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of BEXIMCO PHARMAGDR REGS. We use our internally-developed statistical techniques to arrive at the intrinsic value of BEXIMCO PHARMAGDR REGS based on widely used predictive technical indicators. In general, we focus on analyzing BEXIMCO Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build BEXIMCO PHARMAGDR's daily price indicators and compare them against related drivers.

When running BEXIMCO PHARMAGDR's price analysis, check to measure BEXIMCO PHARMAGDR's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BEXIMCO PHARMAGDR is operating at the current time. Most of BEXIMCO PHARMAGDR's value examination focuses on studying past and present price action to predict the probability of BEXIMCO PHARMAGDR's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BEXIMCO PHARMAGDR's price. Additionally, you may evaluate how the addition of BEXIMCO PHARMAGDR to your portfolios can decrease your overall portfolio volatility.